CD8A and COVID-19: Indeed, clinical outcomes in COVID-19 are at least partly determined by the functional capacity of T-cell responses: efficient viral clearance and mild disease are associated with a rapid induction of CD4+ and CD8+ T-cells, whereas severe disease and fatal outcomes are more likely in the absence of these responses [1,9,14].